Cargando…

Targeting Chromatin Regulation in Acute Myeloid Leukemia

Detalles Bibliográficos
Autores principales:	Richardson, Simon E., Huntly, Brian J. P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2021
Materias:	Perspective
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8171376/ https://www.ncbi.nlm.nih.gov/pubmed/34095772 http://dx.doi.org/10.1097/HS9.0000000000000589

Ejemplares similares

The RNA editing landscape in acute myeloid leukemia reveals associations with disease mutations and clinical outcome
por: Meduri, Eshwar, et al.
Publicado: (2022)

Molecular Landscape of Acute Myeloid Leukemia: Prognostic and Therapeutic Implications
por: Marando, Ludovica, et al.
Publicado: (2020)

Acute myeloid leukemia: leukemia stem cells write a prognostic signature
por: Gudgin, Emma J, et al.
Publicado: (2011)

Targeting IDH1 and IDH2 Mutations in Acute Myeloid Leukemia: Emerging Options and Pending Questions
por: Wouters, Bas J.
Publicado: (2021)

Pharmacologic Targeting of Chromatin Modulators As Therapeutics of Acute Myeloid Leukemia
por: Lu, Rui, et al.
Publicado: (2017)

Polo-like kinase inhibition as a therapeutic target in acute myeloid leukemia
por: Bewersdorf, Jan Philipp, et al.
Publicado: (2021)

Similarities and Differences Between Therapy-Related and Elderly Acute Myeloid Leukemia
por: D’Alò, Francesco, et al.
Publicado: (2011)

Chromatin-Spliceosome Mutations in Acute Myeloid Leukemia
por: Ochi, Yotaro, et al.
Publicado: (2021)

Advances in culture methods for acute myeloid leukemia research
por: Syama, Krishnapriya, et al.
Publicado: (2021)

Chromatin Complexes Maintain Self-Renewal of Myeloid Progenitors in AML: Opportunities for Therapeutic Intervention
por: Uckelmann, Hannah J., et al.
Publicado: (2020)

Epidemiology of Therapy-Related Myeloid Neoplasms After Treatment for Pediatric Acute Lymphoblastic Leukemia in the Nordic Countries.
por: Schmiegelow, Kjeld
Publicado: (2011)

The role of BET epigenetic readers in acute myeloid leukaemia and other haematological malignancies
por: Huntly, Brian
Publicado: (2013)

Paradoxical down-regulation of p16(INK4a) mRNA with advancing age in Acute Myeloid Leukemia
por: de Jonge, Hendrik J.M., et al.
Publicado: (2009)

P424: LANDSCAPE OF CHROMATIN ACCESSIBILITY IN ACUTE MYELOID LEUKEMIA
por: Ochi, Yotaro, et al.
Publicado: (2023)

Next-generation sequencing in the diagnosis and minimal residual disease assessment of acute myeloid leukemia
por: Levine, Ross L., et al.
Publicado: (2019)

Chimeric antigen receptor T-cell therapy for acute myeloid leukemia: how close to reality?
por: Cummins, Katherine D., et al.
Publicado: (2019)

Chronic myeloid leukemia stem cells in the era of targeted therapies: resistance, persistence and long-term dormancy
por: Chomel, Jean-Claude, et al.
Publicado: (2011)

How I Manage Patients with Chronic Myeloid Leukemia (CML): Perspectives from Clinical Practice
por: Guru Murthy, Guru Subramanian
Publicado: (2022)

Targeting regulated cell death pathways in acute myeloid leukemia
por: Garciaz, Sylvain, et al.
Publicado: (2023)

Unified classification and risk-stratification in Acute Myeloid Leukemia
por: Tazi, Yanis, et al.
Publicado: (2022)

KAT7 is a genetic vulnerability of acute myeloid leukemias driven by MLL rearrangements
por: Au, Yan Zi, et al.
Publicado: (2021)

Molecular targeting in acute myeloid leukemia
por: Lim, Seah H., et al.
Publicado: (2017)

A CRISPR Dropout Screen Identifies Genetic Vulnerabilities and Therapeutic Targets in Acute Myeloid Leukemia
por: Tzelepis, Konstantinos, et al.
Publicado: (2016)

KDM4B promotes acute myeloid leukemia associated with AML1‐ETO by regulating chromatin accessibility
por: Ueda, Takeshi, et al.
Publicado: (2021)

t(8;21) Acute Myeloid Leukemia as a Paradigm for the Understanding of Leukemogenesis at the Level of Gene Regulation and Chromatin Programming
por: Kellaway, Sophie, et al.
Publicado: (2020)

The New Frontier of Functional Genomics: From Chromatin Architecture and Noncoding RNAs to Therapeutic Targets
por: Papanicolaou, Natali, et al.
Publicado: (2020)

Therapeutic targeting of leukemia stem cells in acute myeloid leukemia
por: Barbosa, Karina, et al.
Publicado: (2023)

The chromatin-remodeling factor CHD4 is required for maintenance of childhood acute myeloid leukemia
por: Heshmati, Yaser, et al.
Publicado: (2018)

Long Non-coding RNAs as Functional and Structural Chromatin Modulators in Acute Myeloid Leukemia
por: Wurm, Alexander A., et al.
Publicado: (2019)

Epigenetic Regulators in the Development, Maintenance, and Therapeutic Targeting of Acute Myeloid Leukemia
por: Sun, Younguk, et al.
Publicado: (2018)

Evaluation of chromatin mesoscale organization
por: Lorber, Dana, et al.
Publicado: (2022)

WHO 2016 Definition of Chronic Myeloid Leukemia and Tyrosine Kinase Inhibitors
por: Haznedaroğlu, İbrahim C., et al.
Publicado: (2020)

Targeting MTHFD2 in acute myeloid leukemia
por: Pikman, Yana, et al.
Publicado: (2016)

Acute myeloid leukemia targets for bispecific antibodies
por: Hoseini, S S, et al.
Publicado: (2017)

Acute myeloid leukemia targets for bispecific antibodies
por: Hoseini, S S, et al.
Publicado: (2017)

Advances in targeted therapy for acute myeloid leukemia
por: Yu, Jifeng, et al.
Publicado: (2020)

Targeting Approaches of Nanomedicines in Acute Myeloid Leukemia
por: Huang, Xiao, et al.
Publicado: (2019)

Targeting Metabolic Reprogramming in Acute Myeloid Leukemia
por: Castro, Isabel, et al.
Publicado: (2019)

Resistance to targeted therapies in acute myeloid leukemia
por: Mecklenbrauck, Rabea, et al.
Publicado: (2022)

Targeted Therapy Development in Acute Myeloid Leukemia
por: Totiger, Tulasigeri M., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_upgtbvf9dkm9uaal0qpbjonibf